Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / LevitasBio, Inc.

LevitasBio, Inc.

Stage unknownMenlo Park, CAlevitasbio.comOther Technology

Next generation tools for sample preparation and characterization, ensuring the best results with simple to complex samples

Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Mar 28, 2024
    Form D equity offering · $11.8M (form d sold) · 3 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “LevitasBio, Inc. filed Form D: $11,759,181 sold of $25,059,184, Other Technology”
Investors on record
1 edges
People
1 officers, 5 directors
Timeline
1
  1. Apr 10, 2024
    LevitasBio, Inc. filed Form D: $11,759,181 sold of $25,059,184, Other Technology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
19 observations
Every observation on this company